CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease

Overview of attention for article published in Frontiers in Aging Neuroscience, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 76,211 followers.

Nanoliposomal GM1 offers targeted delivery & enhanced efficacy. Hope for PD patients worldwide! #Parkinsons #GM1 #NanoliposomalGM1 #Innomedica #MedicalResearch #BrainHealth Read more: [https://t.co/5wIgAOiVmF] Learn about Innomedica's groundbreaking w

17 Jul 2023

Reply Repost Favourite

RT @FrontNeurosci: New Research: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease: Introduction The t…

20 Jun 2023

Reply Repost Favourite

New Research: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease: Introduction The treatment with monosialotetrahexosylganglioside (GM1) improves the symptoms of Parkinson’s disease (PD). The… #ageing #neuroscience https

20 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.